Male Osteoporosis Study
Osteoporosis is an important public health problem affecting both men and women. In elderly men it is an important cause of mortality and morbidity. Information on specific therapies for male osteoporosis is almost limited to oral bisphosphonates, as being the only currently approved therapy in the indication of male osteoporosis. This study is designed to assess the safety of an intravenous bisphosphonate administered annually.
This two-year study aims to determine if this new treatment has beneficial effects in treating osteoporosis by reducing bone loss and fractures in men. The treatment includes a yearly injection plus daily vitamin D and calcium supplements. This study will involve visiting the Research Unit for a total of 12 visits over the two (2) year study period.
Back to Current Research